Top Markets
#1 Islamic Coin Islamic Coin +151.49%
#2 DOVU DOVU +48.16%
#3 Velvet Velvet +44.46%
#4 Akedo Akedo +40.57%
#5 Black Phoenix Black Phoenix +33.98%
#6 Cross Cross +24.15%
#7 Cap Cap +20.35%
#8 DoubleZero DoubleZero +14.60%
#9 Tutorial Tutorial +11.59%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.77%
Coin of the day
Islamic Coin Islamic Coin
설정
언어
한국어
통화
USD
테마
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
주식 순위 #41091
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
주가
$0.0202
마지막 동기화: 2024-11-19
시가총액
$44.67K
변동 (1일)
-0.49%
변동 (1년)
0.00%
국가
IL
거래 Notable Labs, Ltd. (NTBL)

카테고리

Healthcare
Notable Labs, Ltd. (NTBL)의 수익
Jun 2024 기준 수익 TTM: $-8.99M
Notable Labs, Ltd.의 최신 재무 보고서에 따르면 회사의 현재 수익은 $-8.99M입니다. 2022년에 회사는 $-14.41M의 수익을 올렸으며 이는 2021년의 수익 $-16.05M과 증가입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Notable Labs, Ltd.의 수익 기록 (2015 ~ 2026)
연말 수익
연도 수익 변화
2026 (TTM) $-8.99M -20.23%
2023 $-11.26M -21.82%
2022 $-14.41M -10.25%
2021 $-16.05M -33.74%
2020 $-24.23M 24.90%
2019 $-19.40M -5.19%
2018 $-20.46M 101.80%
2017 $-10.14M -36.65%
2016 $-16.00M 7.48%
2015 $-14.89M 0.00%
유사 기업 또는 경쟁사의 수익
회사 수익 수익 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -58,807.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -21,810.07%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -33,552.61%
BE